Summit Therapeutics (SMMT) on Thursday filed a registration statement for a potential secondary offering of about 10.4 million common shares.
The company said the selling stockholders may offer and sell the shares from time to time through public or private transactions.
The company is not selling any shares in the potential offering and will not receive any proceeds from it.
Price: 23.20, Change: +0.04, Percent Change: +0.17
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments